{"pub": "wsj", "url": "https://barrons.com/articles/a-big-cancer-conference-could-yield-breakthroughs-51569507214?mod=rsswn", "downloaded_at": "2019-09-26 15:08:14.542635+00:00", "title": "A Big Cancer Conference Starts Tomorrow. Here\u2019s What It Means for Merck, Bristol-Myers and Other Drug Stocks.", "language": "en", "text": "A Big Cancer Conference Starts Tomorrow. Here\u2019s What It Means for Merck, Bristol-Myers and Other Drug Stocks.\n\nText size\n\nPhotograph by Ousa Chea\n\nA major cancer conference is kicking off in Barcelona on Friday, and while health-care and biotech analysts kiss their weekends goodbye, investors are bracing for a barrage of big news on clinical trials from companies such as Merck , Bristol-Myers Squibb , and others.\n\nThe conference, put on by the European Society for Medical Oncology, runs through next Tuesday, and includes panels, symposia, and presentations. Scientists have submitted nearly 4,000 study abstracts.\n\nEditor's Choice\n\nBelow are some things investors should be watching out for.", "description": "A major cancer conference is kicking off in Barcelona on Friday, and while health-care and biotech analysts kiss their weekends goodbye, investors are bracing for a barrage of big news on clinical trials from companies such as Merck, Bristol-Myers, and others.", "authors": ["Josh Nathan-Kazis"], "top_image": "https://images.barrons.com/im-111130/social", "published_at": "2019-09-26"}